Canada markets open in 29 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.16000.0000 (0.00%)
At close: 11:24AM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 17.80M
Enterprise Value 21.15M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.90
Price/Book (mrq)107.98
Enterprise Value/Revenue 14.55
Enterprise Value/EBITDA -5.28

Trading Information

Stock Price History

Beta (5Y Monthly) 0.30
52-Week Change 314.29%
S&P500 52-Week Change 323.73%
52 Week High 30.2400
52 Week Low 30.1100
50-Day Moving Average 30.1636
200-Day Moving Average 30.1713

Share Statistics

Avg Vol (3 month) 340.7k
Avg Vol (10 day) 329.48k
Shares Outstanding 5114.81M
Implied Shares Outstanding 6N/A
Float 883.22M
% Held by Insiders 125.46%
% Held by Institutions 10.00%
Shares Short (Nov. 14, 2021) 447.35k
Short Ratio (Nov. 14, 2021) 41.67
Short % of Float (Nov. 14, 2021) 4N/A
Short % of Shares Outstanding (Nov. 14, 2021) 40.04%
Shares Short (prior month Oct. 14, 2021) 423.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar. 12, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar. 12, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin -285.69%
Operating Margin (ttm)-314.61%

Management Effectiveness

Return on Assets (ttm)-50.02%
Return on Equity (ttm)-596.79%

Income Statement

Revenue (ttm)1.45M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)50.10%
Gross Profit (ttm)526.86k
Net Income Avi to Common (ttm)-4.15M
Diluted EPS (ttm)-0.0350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.29M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)4.66M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.72
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-4.02M
Levered Free Cash Flow (ttm)-2.71M